TELA Bio cuts workforce 20%, CFO/COO Cuca steps down; annual savings $17M

TELA Bio, Inc.

Reduces workforce ~20% (201 to 160 employees); expects $1.5M Q3 2026 restructuring charge.
Annual operating expense reduction of $17.0M (18%) via headcount and external resource streamlining.
Roberto Cuca steps down as CFO/COO and Corporate Secretary effective Aug 31, 2026; Heather Getz named principal financial officer.
Initiative expected to extend cash runway into 2028; details on Q3 2026 earnings call in early November.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.